Severe pulmonary hypertension in postmenopausal obese women

European Journal of Medical Research

Volumn 11, Issue 5, 2006, Pages 198-202

  Taraseviciute, Agne ^a   Voelkel, Norbert F ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Anorexigen; Menopause; Obesity; Severe pulmonary hypertension

Indexed keywords

ANOREXIGENIC AGENT; ANTIDEPRESSANT AGENT; C REACTIVE PROTEIN; CHOLESTEROL; URIC ACID;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DATA COLLECTION METHOD; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENETIC PREDISPOSITION; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL RECORD; OBESITY; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; URIC ACID BLOOD LEVEL;

ANTIDEPRESSIVE AGENTS; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERTENSION, PULMONARY; MALE; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; RETROSPECTIVE STUDIES;

EID: 33646731984     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Tuder, R. M., Yeager, M. E., Geraci, M., Golpon, H. A., and Voelkel, N. F. Severe Pulmonary Hypertension After the Discovery of the Familial Primary Pulmonary Hypertension Gene. Eur Respir J. 2001;17(6):1065-9.
2. Rich, S. Primary Pulmonary Hypertension: Executive Summary, World Symposium on Primary Pulmonary Hypertension. Evian, France.World Health Organization via the internet: www.who.int/ncd/cvd/pph.htlm 1998.
3. Archer, S. and Rich, S. Primary Pulmonary Hypertension: a Vascular Biology and Translational Research "Work in Progress". Circulation. 11-28-2000;102(22):2781-91.
4. Humbert, M. and Trembath, R. C. Genetics of Pulmonary Hypertension: From Bench to Bedside. Eur Respir J. 2002;20(3):741-9.
5. Tuder, R. M., Cool, C. D., Yeager, M., Taraseviciene-Stewart, L., Bull, T. M., and Voelkel, N. F. The Pathobiology of Pulmonary Hypertension. Endothelium. ClinChest Med. 2001;22(3):405-18.
6. Voelkel, N. F. and Tuder, R. M. Cellular and Molecular Mechanisms in the Pathogenesis of Severe Pulmonary Hypertension. Eur Respir J. 1995;8(12):2129-38.
7. Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., Simonneau, G., and Begaud, B. Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med. 8-29-1996;335(9):609-16.
8. Mehra, N. J., Khan, I. A., Mehta, R. N., and Sepkowitz, D. A. HIV-Related Pulmonary Hypertension: Analytic Review of 131 Cases. Chest. 2000;118(4):1133-41.
9. Kuczmarski, R. J., Carroll, M. D., Flegal, K. M., and Troiano, R. P. Varying Body Mass Index Cutoff Points to Describe Overweight Prevalence Among U.S. Adults: NHANES III (1988 to 1994). Obes.Res. 1997;5(6):542-8.
10. Voelkel, N. F. Appetite Suppressants and Pulmonary Hypertension. Thorax. 1997;52 Suppl 3:S63-S67.
11. Voelkel, N. F. Primary Pulmonary Hypertension. Lung Biology in Health and Disease.Marcel Dekker, Basel-New York; 1979. pp.573-628.
12. Spyridopoulos, I., Sullivan, A. B., Kearney, M., Isner, J. M., and Losordo, D. W. Estrogen-Receptor-Mediated Inhibition of Human Endothelial Cell Apoptosis. Estradiol As a Survival Factor. Circulation. 3-18-1997;95(6):1505-14.
13. Lee, S. L., Wang, W. W., Moore, B. J., and Fanburg, B. L. Dual Effect of Serotonin on Growth of Bovine Pulmonary Artery Smooth Muscle Cells in Culture. Circ Res. 1991;68(5):1362-8.
14. Morse, J. H., Horn, E. M., and Barst, R. J. Hormone Replacement Therapy: a Possible Risk Factor in Carriers of Familial Primary Pulmonary Hypertension. Chest. 1999; 116(3):847.
15. Voelkel, M. A., Wynne, K. M., Badesch, D. B., Groves, B. M., and Voelkel, N. F. Hyperuricemia in Severe Pulmonary Hypertension. Chest. 2000;117(1):19-24.
16. Pradhan, A. D., Manson, J. E., Rossouw, J. E., Siscovick, D. S., Mouton, C. P., Rifai, N., Wallace, R. B., Jackson, R. D., Pettinger, M. B., and Ridker, P. M. Inflammatory Biomarkers, Hormone Replacement Therapy, and Incident Coronary Heart Disease: Prospective Analysis From the Women's Health Initiative Observational Study. JAMA. 8-28-2002;288(8):980-7.
17. Badesch, D. B., Wynne, K. M., Bonvallet, S., Voelkel, N. F., Ridgway, C., and Groves, B. M. Hypothyroidism and Primary Pulmonary Hypertension: an Autoimmune Pathogenetic Link? Ann Intern Med. 7-1-1993;119(1):44-6.
18. Gargett, C. E., Zaitseva, M., Bucak, K., Chu, S., Fuller, P. J., and Rogers, P. A. 17Beta-Estradiol Up-Regulates Vascular Endothelial Growth Factor Receptor-2 Expression in Human Myometrial Microvascular Endothelial Cells: Role of Estrogen Receptor-Alpha and -Beta. J Clin Endocrinol Metab. 2002;87(9):4341-9.
19. Sitbon, O., Humbert, M., Jagot, J. L., Taravella, O., Fartoukh, M., Parent, F., Herve, P., and Simonneau, G. Inhaled Nitric Oxide As a Screening Agent for Safely Identifying Responders to Oral Calcium-Channel Blockers in Primary Pulmonary Hypertension. Eur Respir J. 1998; 12 (2): 265-70.
20. Belgore, F. M., Lip, G. Y., and Blann, A. D. Successful Therapy Reduces Levels of Vascular Endothelial Growth Factor (VEGF) in Patients With Hypertension and Patients With Hypercholesterolemia. Atherosclerosis. 2000; 151(2):599.
21. Eddahibi, S., Humbert, M., Fadel, E., Raffestin, B., Darmon, M., Capron, F., Simonneau, G., Dartevelle, P., Hamon, M., and Adnot, S. Serotonin Transporter Overexpression Is Responsible for Pulmonary Artery Smooth Muscle Hyperplasia in Primary Pulmonary Hypertension. J Clin Invest. 2001;108(8):1141-50.
22. Tuder, R. M., Chacon, M., Alger, L., Wang, J., Taraseviciene-Stewart, L., Kasahara, Y., Cool, C. D., Bishop, A. E., Geraci, M., Semenza, G. L., Yacoub, M., Polak, J. M., and Voelkel, N. F. Expression of Angiogenesis-Related Molecules in Plexiform Lesions in Severe Pulmonary Hypertension: Evidence for a Process of Disordered Angiogenesis. J Pathol. 2001;195(3):367-74.
23. Gruber, C. J., Tschugguel, W., Schneeberger, C., and Huber, J. C. Production and Actions of Estrogens. N Engl J Med. 1-31-2002;346(5):340-52.
24. Castracane, V. D., Kraemer, R. R., Franken, M. A., Kraemer, G. R., and Gimpel, T. Serum Leptin Concentration in Women: Effect of Age, Obesity, and Estrogen Administration. Fertil Steril. 1998;70(3):472-7.
25. Sierra-Honigmann, M. R., Nath, A. K., Murakami, C., Garcia-Cardena, G., Papapetropoulos, A., Sessa, W. C., Madge, L. A., Schechner, J. S., Schwabb, M. B., Polverini, P. J., and Flores-Riveros, J. R. Biological Action of Leptin As an Angiogenic Factor. Science. 9-11-1998;281(5383): 1683-6.
26. Hyder, S. M., Nawaz, Z., Chiappetta, C., and Stancel, G. M. Identification of Functional Estrogen Response Elements in the Gene Coding for the Potent Angiogenic Factor Vascular Endothelial Growth Factor. Cancer Res. 6-15-2000;60(12):3183-90.
27. Suzuma, I., Mandai, M., Takagi, H., Suzuma, K., Otani, A., Oh, H., Kobayashi, K., and Honda, Y. 17 Beta-Estradiol Increases VEGF Receptor-2 and Promotes DNA Synthesis in Retinal Microvascular Endothelial Cells. Invest Ophthalmol Vis Sci. 1999;40(9):2122-9.
28. Messinis, I. E., Kariotis, I., Milingos, S., Kollios, G., and Seferiadis, K. Treatment of Normal Women With Oestradiol Plus Progesterone Prevents the Decrease of Leptin Concentrations Induced by Ovariectomy. Hum Reprod. 2000;15(11):2383-7.
29. Shimizu, H., Shimomura, Y., Nakanishi, Y., Futawatari, T., Ohtani, K., Sato, N., and Mori, M. Estrogen Increases in Vivo Leptin Production in Rats and Human Subjects. J Endocrinol. 1997;154(2):285-92.
30. Agrawal, R., Prelevic, G., Conway, G. S., Payne, N. N., Ginsburg, J., and Jacobs, H. S. Serum Vascular Endothelial Growth Factor Concentrations in Postmenopausal Women: the Effect of Hormone Replacement Therapy. Fertil Steril. 2000;73(1):56-60.
31. Sandler, M. Is the Lung a 'Target Organ' in Diabetes Mellitus? Arch Intern Med. 1990;150(7):1385-8.
32. Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., and Baron, A. D. Obesity/Insulin Resistance Is Associated With Endothelial Dysfunction. Implications for the Syndrome of Insulin Resistance. J Clin Invest. 6-1-1996;97(11):2601-10.
33. Loscalzo, J. Endothelial Dysfunction in Pulmonary Hypertension. N Engl J Med. 7-9-1992;327(2):117-9.